Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


Cardio-ankle Vascular Index (CAVI) in Hypertension Patients After One Year of Treatment
Condition:   Hypertension
Intervention:   Procedure: Hypertension outpatient treatment
Sponsor:   Hanoi Medical University
Completed

Fri, 21 Sep 2018 12:00:00 EDT


Dietary Management of Gestational Diabetes
Conditions:   Diabetes, Gestational;   Dietary Modification;   Glucose Intolerance During Pregnancy;   Body Composition;   Birth Weight
Interventions:   Other: Carbohydrate restricted diet;   Other: Plant-protein based diet
Sponsors:   Helsinki University Central Hospital;   Helsinki University;   Aalto University;   National Institute for Health and Welfare, Finland;   City of Helsinki;   UKK Institute
Not yet recruiting

Fri, 21 Sep 2018 12:00:00 EDT


Gastroparesis Registry 3
Conditions:   Gastroparesis;   Diabetic Gastroparesis;   Idiopathic Gastroparesis
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting

Fri, 21 Sep 2018 12:00:00 EDT


High Risk Youth With Poorly-controlled Diabetes
Condition:   Type 1 Diabetes Mellitus
Intervention:   Other: Group education sessions
Sponsor:   Washington University School of Medicine
Recruiting

Fri, 21 Sep 2018 12:00:00 EDT


Pediatric Gastroparesis Registry
Conditions:   Gastroparesis;   Gastroparesis-like Syndrome
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting

Fri, 21 Sep 2018 12:00:00 EDT


Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies
Conditions:   Diabetic Retinopathy;   Retinal Vein Occlusion
Intervention:   Other: sampling of ophthalmic liquid
Sponsor:   CHU de Reims
Recruiting

Fri, 21 Sep 2018 12:00:00 EDT


To Compare the Effects of Non-nutritive Sweeteners Intake in Subjects With T2DM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Other: To assess the effect of ingestion of a sucralose sweetener preload and steviol glycosides versus water
Sponsors:   University of Chile;   Sociedad Chilena de Nutrición
Completed

Fri, 21 Sep 2018 12:00:00 EDT


Characteristics of Marrow Fatty Cells in the Ageing of Bone and Joints, Osteoarthritis and Osteoporosis
Conditions:   Osteoarthritis, Knee;   Prosthesis User
Intervention:   Procedure: tissue
Sponsors:   University Hospital, Lille;   MSDAVENIR Foundation
Not yet recruiting

Thu, 20 Sep 2018 12:00:00 EDT


Creative Writing for Type 2 Diabetes Management
Condition:   Diabetes
Interventions:   Behavioral: CrewD Program;   Behavioral: Classical structured education
Sponsor:   Associacao Protectora dos Diabeticos de Portugal
Completed

Thu, 20 Sep 2018 12:00:00 EDT


Effect of Exercise on Cardiometabolic Profile in Women With Polycystic Ovary Syndrome
Condition:   Polycystic Ovary Syndrome
Interventions:   Behavioral: Exercise Intervention;   Behavioral: Lifestyle Physical Activity
Sponsors:   Sheffield Hallam University;   Sheffield Teaching Hospitals NHS Foundation Trust
Not yet recruiting

Thu, 20 Sep 2018 12:00:00 EDT


FitMum: Fitness for Good Health of Mother and Child
Conditions:   Pregnancy Related;   Physical Activity
Interventions:   Behavioral: Structured supervised exercise training;   Behavioral: Motivational counseling supported by health technology
Sponsors:   Nordsjaellands Hospital;   Technical University of Denmark;   University of Aarhus;   University of Graz;   Deakin University;   University of Copenhagen
Not yet recruiting

Thu, 20 Sep 2018 12:00:00 EDT


Nutritional Supplement on Wound Healing in Diabetic Foot
Condition:   Diabetic Foot
Intervention:   Dietary Supplement: Abound
Sponsor:   Chang Gung Memorial Hospital
Recruiting

Thu, 20 Sep 2018 12:00:00 EDT


Stanford Clinics Physician Mindset Training
Conditions:   Diabetes;   Diabetes Mellitus;   Hypertension;   Pre Diabetes;   Overweight and Obesity
Intervention:   Behavioral: Mindset & Communication Training
Sponsor:   Kari Alyse Leibowitz
Enrolling by invitation

Wed, 19 Sep 2018 12:00:00 EDT


A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus
Conditions:   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2
Intervention:   Drug: Insulin degludec
Sponsor:   Novo Nordisk A/S
Not yet recruiting

Tue, 18 Sep 2018 12:00:00 EDT


A Clinical Trial of Low-Carbohydrate Dietary Pattern on Glycemic Outcomes
Conditions:   Diabetes;   PreDiabetes;   Metabolic Disease;   Hyperglycemia;   Diet Modification;   Glucose Intolerance;   Glucose Metabolism Disorders (Including Diabetes Mellitus);   Endocrine System Diseases
Intervention:   Behavioral: Low-Carbohydrate Diet
Sponsors:   Tulane University School of Public Health and Tropical Medicine;   National Institute of General Medical Sciences (NIGMS)
Not yet recruiting

Tue, 18 Sep 2018 12:00:00 EDT
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s ongoing efforts to prevent foodborne outbreaks of <i>Cyclospora</i>
he safety of the American food supply is one of the U.S. Food and Drug Administration’s highest priorities. A key part of our work in this space focuses on implementing the principles and measures of the FDA Food Safety Modernization Act (FSMA). The actions directed by FSMA are designed to prevent foodborne illness and food safety problems from happening.

Tue, 18 Sep 2018 16:47:00 -0400


FDA takes important steps to encourage appropriate and rational prescribing of opioids through final approval of new safety measures governing the use of immediate-release opioid analgesic medications
FDA takes important steps to encourage appropriate and rational prescribing of opioids through final approval of new safety measures governing the use of immediate-release opioid analgesic medications.

Tue, 18 Sep 2018 13:59:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kids
Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kids.

Tue, 18 Sep 2018 09:34:00 -0400


FDA launches new, comprehensive campaign to warn kids about the dangers of e-cigarette use as part of agency’s Youth Tobacco Prevention Plan, amid evidence of sharply rising use among kids
FDA launched new, comprehensive campaign to warn kids about the dangers of e-cigarette use as part of agency’s Youth Tobacco Prevention Plan, amid evidence of sharply rising use among kids.

Tue, 18 Sep 2018 08:58:00 -0400


FDA approves device for treatment of acute coronary artery perforations
FDA approves device for treatment of acute coronary artery perforations

Fri, 14 Sep 2018 12:08:00 -0400


Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s commitment to studying breast implant safety
FDA Statement on agency’s commitment to studying breast implant safety Short Title: FDA Statement on agency’s commitment to studying breast implant safety

Fri, 14 Sep 2018 11:49:00 -0400


FDA provides update on its ongoing investigation into valsartan products; and reports on the finding of an additional impurity identified in one firm’s already recalled products
FDA update on the ongoing investigation into valsartan impurities, recalls and current findings.

Thu, 13 Sep 2018 16:12:00 -0400


FDA approves new kind of treatment for hairy cell leukemia
FDA approves Lumoxiti (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukemia

Thu, 13 Sep 2018 13:54:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., and Center for Devices and Radiological Health Director Jeff Shuren, M.D., J.D., on agency efforts to work with tech industry to spur innovation in digital health
FDA Statement on agency efforts to work with tech industry to spur innovation in digital health

Wed, 12 Sep 2018 13:43:00 -0400


FDA awards five grants to advance the development of pediatric medical devices
FDA has awarded grants to five Pediatric Device Consortia that will provide advice to innovators of children's medical devices

Wed, 12 Sep 2018 12:27:00 -0400
Diabetes news from the American Diabetes Association

Latest Top (5) News